麻杏石甘汤靶向肺炎链球菌溶血素抑制其致病性
该研究探讨经典方剂麻杏石甘汤(MXSGT)是否通过靶向肺炎链球菌溶血素(PLY)抑制细菌毒力。体外实验显示MXSGT抑制PLY寡聚化而不影响细菌生长与PLY产生,并减少PLY介导的A549细胞死亡;小鼠实验验证其对肺部感染有效。
要点
- 麻杏石甘汤可抑制肺炎链球菌溶血素(PLY)的寡聚化,而不影响细菌生长。
- 体外实验显示MXSGT减少PLY介导的A549细胞死亡。
- 小鼠实验提示MXSGT对肺炎链球菌感染有效,支持其临床用于肺炎球菌病的潜力。
核心结论
- 麻杏石甘汤是肺炎链球菌溶血素(PLY)的有效抑制剂,可抑制PLY寡聚化而不影响细菌生长与PLY产生。
- 体外与小鼠实验均显示MXSGT对肺炎链球菌感染有效,提示其治疗肺炎球菌病的潜在机制。
研究设计与样本
- 研究采用HPLC分析麻杏石甘汤主要成分,构建PLY蛋白进行溶血实验和western blot检测其对PLY活性、产生及寡聚化的抑制。
- 绘制有或无MXSGT处理下肺炎链球菌的生长曲线,用细胞毒性实验检测MXSGT对PLY介导的A549细胞死亡的抑制作用,最后用小鼠实验验证对肺部的影响。
主要发现
- MXSGT抑制PLY的寡聚化,而不影响肺炎链球菌生长和PLY产生。
- MXSGT在体外和小鼠体内实验中均对肺炎链球菌感染有效。
临床怎么用
- 该研究为麻杏石甘汤治疗肺炎球菌病提供了靶向PLY的潜在机制证据,支持其在临床中更广泛使用的可能性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
ETHNOPHARMACOLOGICAL RELEVANCE: Ma-xing-shi-gan-tang (MXSGT), which is documented in the Treatise on Febrile Diseases and is a therapeutic drug, is a well-known classic prescription in China and has been widely studied. Previous studies have shown that MXSGT has various pharmacological activities, including anti-influenza virus activity, and ameliorates microvascular hyperpermeability and inflammatory reactions. However, no study has reported the effect of MXSGT in the treatment of bacterial pneumonia. AIM OF THE STUDY: In this study, the potential inhibition of MXSGT against the virulence of S. pneumoniae by targeting PLY was investigated. MATERIALS AND METHODS: First, HPLC analysis was used to determine the main components of MXSGT. Then PLY protein was constructed and used for hemolysis assay and western blot to test the ability of MXSGT to inhibit PLY activity, production and widowed characteristics. The growth curve of S. pneumoniae was drawled with or without MXSGT treatment. In addition, the inhibition of MXSGT against PLY-mediated A549 cell death was examined by cytotoxicity assay. Finally, the mouse experiment was used to verify the effect of MXSGT on mouse lungs. RESULTS: This work has discovered that MXSGT, a TCM prescription, is an effective inhibitor of PLY, an important virulence factor that is essential for S. pneumoniae pathogenicity. MXSGT inhibits the oligomerization of PLY without affecting S. pneumoniae growth and PLY production. In addition, experimental MXSGT treatment was effective against S. pneumoniae infection both in vitro and in vivo. CONCLUSION: These findings directly demonstrate the potential mechanism of the Chinese herbal formula MXSGT in the treatment of pneumococcal disease and provide additional evidence for promotion of the wide use of MXSGT in the clinic.
引用
- Guo T, Guo Y, Liu Q, et al. The TCM prescription Ma-xing-shi-gan-tang inhibits Streptococcus pneumoniae pathogenesis by targeting pneumolysin. J Ethnopharmacol. 2021. PMID: 33892068. doi:10.1016/j.jep.2021.114133
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。